16 classic growth stocks too good to ignore Robust sales

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz RobInvest #34300
16 classic growth stocks too good to ignore
Robust sales gains, year after year, are hard to achieve -- but not for these companies. Here's why.
By StreetAuthority 21 hours ago



Home under construction © CorbisBy David Sterman

In terms of revenues, Amazon.com (AMZN) is the classic growth stock.

Its sales have grown at least 20 percent for 20 straight years, and analysts think the winning streak will continue, with consensus projected sales growth of 20.7 percent this year (to an eye-popping $89 billion). Yet in 2015, this remarkable streak may come to an end, as sales growth slips to just 19 percent.

Amazon's streak of 20 percent sales growth got me thinking. How hard is it to maintain a robust growth pace? Very hard, as it turns out. Of the 1,500 companies in the S&P 400, 500 and 600, only 16 of them are expected to boost sales at least 20 percent in 2014, 2015 and 2016.

Of these 16, special mention goes to Facebook (FB) and Priceline.com (PCLN). These companies are on pace for than $10 billion in sales by next year and are fighting the "Laws of Bigness." (However, a massive wave of insider selling at Priceline last month led me to wonder if that company's robust growth streak can really be maintained.)

The group of 16 growth stocks represents various parts of the U.S. economy, highlighting the fact that strong market share strategies can pay off in almost any industry.
Take Cabot Oil & Gas (COG) as an example. As I noted earlier this month, Cabot's current drilling plans are expected to lead to a big spike in output over the next few years. The company's executives decided to plow ahead with development plans, even as rivals were retrenching. The fact that natural gas prices have risen more than 10 percent in the past three weeks simply underscores the wisdom of that strategy, and could lead to rising sales and profit estimates.

Strong growth also brings intangible rewards. Athletic apparel maker Under Armour (UA), which is one of the elite 16 growers (and which my colleague Melvin Pasternak profiled last week), has just been invited to join the S&P 500. The company just exceeded first-quarter sales and profits forecasts, and "based on current momentum and updated outlook, UA remains well positioned to further raise guidance over the balance of the year," predict analysts at D.A. Davidson. A 20 percent pullback in this stock over the past month is the kind of entry point that long-term growth-oriented investors look for.

Growth interrupted
Of course, in many cyclical industries, it's impossible to maintain very strong growth rates when the economy slumps. And that was a lesson learned by Eagle Materials (EXP), a maker of drywall, cement and other materials used in homebuilding. Eagle experienced solid growth a decade ago, but when the housing market tanked, so did Eagle's revenue base. Sales fell by half from fiscal 2007 through fiscal 2011 (to around $460 million).

Yet even before the pace of home construction returns to normal levels, Eagle is again experiencing solid growth: Sales are now growing at a 30 percent pace and are expected to surpass $1.1 billion in the current fiscal year, which began this month. That's 25 percent higher than the peak in fiscal 2007, and it's setting the stage for solid profit growth: Earnings per share (EPS) are growing at a 50 percent pace these days, a pace which could be sustained for an extended period if the housing market finally starts to grow at a solid clip.

A biotech tweener
Growth-oriented investors should also check out Alexion Pharmaceuticals (ALXN), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20 percent to 25 percent growth appears locked in over coming years as well. Analysts at UBS, who see 30 percent upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario.

Risks to consider: These companies have been delivering solid growth in a slowly improving economy, and would be hard-pressed to maintain growth if the economy slumps. Moreover, such impressive growers are rarely cheap, so these stocks could prove to be more vulnerable than most if the market sharply pulls back.

Action to take: These companies share the common trait of market share gains, and rising market share tends to correlate with rising profit margins. Indeed, many of the companies in this group have an impressive track record of profit margin expansion, and are expected to boost profits even faster than sales in coming years. They are not necessarily good trades, as none of them are dirt-cheap, but should instead be seen as solid buy-and-hold investments.

David Sterman does not personally hold positions in any securities mentioned in this article.
StreetAuthority LLC does not hold positions in any securities mentioned in this article.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 67

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 53

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 35

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

NAL Research Unveils Innovative Tracking Solutions with Iridium

Updated Category News Views 188

NAL Research Integrates Iridium’s Enhanced SBD Service NAL Research, a leader in wireless communication solutions, is excited to announce the incorporation of Iridium's Enhanced Short Burst Data (ESBD) service into its renowned SHOUT product line. This advancement is set to significantly enhance communications security and performance, particularly for users in...

Continue Reading
International Perspectives on China's Growth: A Global Survey Insight

Updated Category News Views 262

Understanding Global Confidence in China's Development As change sweeps across the globe, the perception of China's trajectory is capturing increasing international attention. A recent survey conducted by the Global Times, which engaged over 51,300 respondents from various nations, uncovers valuable insights on how the world views China's growth and development. This...

Continue Reading
SKF Q3 2026: Margins Edge Up Amid Strategic Shifts

Updated Category News Views 192

Cracking Open SKF's Latest Quarterly Numbers Ever seen a company limber up for a big change while tiptoeing through a minefield? That’s SKF for you in this third quarter ending September 2026. Imagine them trying to juggle a spinning platter of growth, strategic separation, and robust margins, all while balancing a wobbly market. A Close Look at Q3's Financial Feats...

Continue Reading
California Oil Refiners' Profits Hit $1.24/Gallon in April

Updated Category News Views 95

California's Refiners Cashing in Big at the Pump Look, when you see profit margins jumping from 49 cents to $1.24 per gallon within a few months, you know the game in California's oil market is something to keep your eye on. The California Energy Commission (CEC) just tossed us a bone with their recent data drop, and it paints a picture of a market with exploding margins,...

Continue Reading
Explore the Growth of Coeur Mining Stock Over a Decade

Updated Category News Views 139

Coeur Mining's Investment Journey Over the Last Decade Coeur Mining Inc (NYSE: CDE) has truly distinguished itself over the past decade, demonstrating a commendable performance that has exceeded market expectations. With an annualized return surpassing the market by 7.64%, investors have seen an impressive average annual return of 20.17%. Today, Coeur Mining boasts a...

Continue Reading